In vitro activities of novel catecholate siderophores against Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 9, 1996, Pages 2094-2098

  Pradines, Bruno ^a,b   Ramiandrasoa, Florence ^c   Basco, Leonardo K ^a   Bricard, Laurent ^c   Kunesch, Gerhard ^c   Le Bras, Jacques ^a  

^a BICHAT HOSPITAL   (France)

^b SERVICE DE SANTÉ DES ARMÉES   (France)

^c UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; BROMIDE; CHLOROQUINE; QUININE; RIBONUCLEOTIDE REDUCTASE; SIDEROPHORE; SPERMIDINE;

ARTICLE; DISEASE PREDISPOSITION; DNA SYNTHESIS; DRUG SENSITIVITY; ENZYME ACTIVITY; IRON CHELATION; MALARIA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

EID: 0029816603     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.9.2094     Document Type: Article

References (33)

1. Atkinson, C. T., M. T. Bayne, V. R. Gordeuk, G. M. Brittenham, and M. Aikawa. 1991. Specific ultrastructural effects of desferrioxamine on Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 45:593-601.
2. Becuwe, P., S. Gratepanche, M. N. Fourmaux, J. Van Beeumen, B. Samyn, O. Mercereau-Puijalon, J. P. Touzel, C. Slomianny, D. Camus, and D. Dive. 1996. Characterization of iron-dependent endogenous superoxide dismutase of Plasmodium falciparum. Mol. Biochem. Parasitol. 76:125-134.
3. Cabantchik, Z. I. 1995. Iron chelators as antimalarials: the biochemical basis of selective cytotoxicity. Parasitol. Today 11:74-78.
4. Chevion, M., L. Chuang, and J. Golenser. 1995. Effects of zinc-desferrioxamine on Plasmodium falciparum in culture. Antimicrob. Agents Chemother. 39:1902-1905.
5. Finkelstein, R. A., C. V. Sciortino, and M. A. McIntosh. 1983. Role of iron in microbe-host interactions. Rev. Infect. Dis. 5:759-776.
6. Fritsch, G., G. Sawatzki, J. Treumer, A. Jung, and D. T. Spira. 1987. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferrithiocin, and desferricrocin. Exp. Parasitol. 63:1-9.
7. Gordeuk, V., P. Thuma, G. Brittenham, C. McLaren, D. Parry, A. Backentose, G. Biemba, R. Msiska, L. Holmes, E. McKinley, L. Vargas, R. Gilkeson, and A. A. Poltera. 1992. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327:1473-1477.
8. Gordeuk, V., P. Thuma, G. Brittenham, S. Zulu, G. Simwanza, A. M'Hango, G. Flesch, and D. Parry. 1992. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood 79: 308-312.
9. Heppner, D. G., P. E. Hallaway, G. J. Kontoghiorghes, and J. W. Eaton. 1988. Antimalarial properties of orally active iron chelators. Blood 72:358-361.
10. Kamchonwongpaisan, S., S. Paitayatat, Y. Thebtaranonth, P. Wilairat, and Y. Yuthavong. 1995. Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators. J. Med. Chem. 38:2311-2316.
11. Kamchonvtongpaisan, S., N. Vanitchareon, and Y. Yuthavong. 1992. The mechanism of antimalarial action of artemisinin, p. 363-372. In A. S. H. Ong and L. Packer (ed.) Lipid-soluble antioxidants: biochemistry and clinical applications. Birkhauser Verlag, Basel.
12. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
13. Le Bras, J., and P. Deloron. 1983. In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. Am. J. Trop. Med. Hyg. 32:447-451.
14. Lytton, S. D., B. Mester, I. Dayan, H. Glickstein, J. Libman, A. Shanzer, and I. Cabantchik. 1993. Mode of action of iron (III) chelators as antimalarials: membrane permeation properties and cytotoxic activity. Blood 81:214-221.
15. Lytton, S. D., B. Mester, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1994. Mode of action of iron (III) chelators as antimalarials. II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis. Blood 84:910-915.
16. Meshnick, S. R., Y. Z. Yang, V. Lima, F. Kuypers, S. Kamchonwongpaisan, and Y. Yuthavong. 1993. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu). Antimicrob. Agents Chemother. 37:1108-1114.
17. Oppenheimer, S. J., S. B. J. MacFarlane, J. B. Moody, O. Bunari, and R. G. Hendrickse. 1986. Effect of iron on morbidity due to infectious disease: report on clinical studies in Papua New Guinea. Trans. R. Soc. Trop. Med. Hyg. 80:596-602.
18. Payne, S. M., and R. A. Finkelstein. 1978. The critical role of iron in host-bacterial inlcractions. J. Clin. Invest. 61:1428-1440.
19. Pollack, S., R. N. Rossan, D. E. Davidson, and A. Escajadillo. 1987. Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys. Proc. Soc. Exp. Biol. Med. 184:162-164.
20. Pouvelle, B., J. A. Gormley, and T. F. Taraschi. 1994. Characterization of trafficking pathways and membrane genesis in malaria-infected erythrocytes. Mol. Biochem. Parasitol. 66:83-96.
21. Raventos-Suarez, C., S. Pollack, and R. L. Nagel. 1982. Plasmodium falciparum: inhibition of in vitro growth by desferrioxamine. Am. J. Trop. Med. Hyg. 31:919-922.
22. Scheibel, L. W., and A. Adler. 1980. Antimalarial activity of selected aromatic chelators. Mol. Pharmacol. 18:320-325.
23. 59 in Plasmodium falciparum in presence of oxines, p. 119-149. In J. W. Eaton, S. R. Meshnick, and G. J. Brewer (ed.), Malaria and the red cells: 2. Alan R. Liss, Inc., New York.
24. Scheibel, L. W., and G. G. Stanton. 1986. Antimalarial activity of selected aromatic chelators. IV. Cation uptake by Plasmodium falciparum in the presence of oxines and siderochromes. Mol. Pharmacol. 30:364-369.
25. Stahel, E., D. Mazier, A. Guillouzo, F. Miltgen, I. Landau, S. Mellouk, R. L. Beaudoin, P. Langlois, and M. Gentilini. 1988. Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria. Am. J. Trop. Med. Hyg. 39:236-240.
26. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
27. Traore, O., P. Carnevale, L. Kaptue-Noche, J. M'Bede, M. Desfontaine, J. Elion, D. Labie, and R. R. Nagel. 1991. Preliminary report on the use of desferrioxamine in the treatment of Plasmodium falciparum malaria. Am. J. Hematol. 37:206-208.
28. Tsafack, A., J. Golenser, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1995. Mode of action of iron (III) chelalors as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Mol. Pharmacol. 47:403-409.
29. Vercellotti, G. M., B. S. VanAsbeck, and H. S. Jacob. 1985. Oxygen radical-induced erythrocyte hemolysis by neutrophils. Critical role of iron and lactoferrin. J. Clin. Invest. 76:956-962.
30. Weinberg, E. D. 1990. Cellular iron metabolism in health and disease. Drug. Metab. Rev. 22:531-579.
31. Whitehead, S., and T. E. A. Peto. 1990. Stage-dependent effect of desferrioxamine on growth of Plasmodium falciparum in vitro. Blood 76:1250-1255.
32. World Health Organization. 1990. Practical chemotherapy of malaria. Technical Report Series 805. World Health Organization, Geneva.
33. Yayon, A., J. A. Vande Waa, M. Yayon, T. G. Geary, and J. B. Jensen. 1984. Stage-dependent effects of chloroquine on Plasmodium falciparum in vitro. J. Protozool. 30:642-647.